Dr. Gill is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
111 S Grant Ave
Ste 208
Columbus, OH 43215Phone+1 614-566-9143Fax+1 614-566-8080
Education & Training
University of Missouri-ColumbiaResidency, Internal Medicine, 2003 - 2006
Des Moines University College of Osteopathic MedicineClass of 2003
Certifications & Licensure
MI State License 2017 - 2027
VA State License 2024 - 2026
IN State License 2009 - 2025
KY State License 2018 - 2025
OH State License 2007 - 2025
WI State License 2024 - 2025- AOA Board of Internal Medicine Critical Care Medicine (CAQ)
- AOA Board of Internal Medicine Pulmonary Diseases
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
Clinical Trials
- Pain and Safety of Microneedles in Oral Cavity Start of enrollment: 2018 Jan 16
Publications & Presentations
PubMed
- Microneedle technology for allergen immunotherapy via the skin.Harvinder Singh Gill
The Journal of Allergy and Clinical Immunology. 2024-03-01 - 4 citationsDelivery of gold nanoparticle-conjugated M2e influenza vaccine in mice using coated microneedles.Lazar D Nesovic, Carsen J Roach, Gaurav Joshi, Harvinder Singh Gill
Biomaterials Science. 2023-08-22 - 4 citationsTreating allergies via skin - Recent advances in cutaneous allergen immunotherapy.Lazar D Nesovic, Akhilesh K Shakya, Harvinder S Gill
Advanced Drug Delivery Reviews. 2022-11-01
Press Mentions
- Review A Practical Guide to the Development of Microneedle Systems – in Clinical Trials or on the MarketOctober 31st, 2019
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
